Table 3.
One-way ANOVA analysis of flow cytometry results for LNCaP Abl.
| Enza | CCG1423 | Enza + CCG1423 | Lesta | Enza + Lesta | |
|---|---|---|---|---|---|
| % G0/G1 Cells | |||||
| Control | NS | 0.0006 | <0.0001 | 0.0004 | NS |
| Enza | - | NS | <0.0001 | NS | NS |
| CCG1423 | - | - | 0.0043 | NS | 0.0359 |
| Enza + CCG1423 | - | - | - | 0.0005 | <0.0001 |
| Lesta | - | - | - | - | 0.036 |
| % S Cells | |||||
| Control | NA | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
| Enza | - | 0.0234 | <0.0001 | <0.0001 | <0.0001 |
| CCG1423 | - | - | 0.0005 | NS | NS |
| Enza + CCG1423 | - | - | - | NS | NS |
| Lesta | - | - | - | - | NS |
| % G2/M Cells | |||||
| Control | NS | NS | NS | NS | <0.0001 |
| Enza | - | NS | NS | NS | <0.0001 |
| CCG1423 | - | - | NS | NS | 0.0001 |
| Enza + CCG1423 | - | - | - | 0.0275 | <0.0001 |
| Lesta | - | - | - | - | NS |
Statistical significance was calculated using One-Way ANOVA (Tukey’s multiple comparisons test). P-value < 0.05 was considered significant. Enza, Enzalutamide; Lesta, Lestaurtinib; NS, non-significant.